Rachel Anatol, PhD

Rachael Anatol, Ph.D., is Senior Vice President for Science and Regulatory Affairs at BIO. In this role, Rachael leads BIO’s science and regulatory advocacy function, manages the BIO Board Regulatory Environment Committee, and advises executive and senior-level BIO staff on BIO’s science and regulatory agenda.

Prior to joining BIO in December 2022, Rachael spent 16 years at the Food and Drug Administration, where she took on roles of increasing responsibility in the Center for Biologics Evaluation and Research, most recently serving as Deputy Director of the Office of Tissues and Advanced Therapies for 6 years.

Rachael received her Ph.D. in molecular and cell biology from the University of Maryland, College Park, and completed her post-doctoral training at NIH’s National Heart, Lung, and Blood Institute.
Speaking In
10:45 AM - 12:00 PM
Wednesday, June 7
The success of the Accelerated Approval pathway has meant countless patients received access to…